CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this document, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this document.
CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 02877) CHANGE OF NAME OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDSThe board (the "Board") of directors (the "Directors") of China Shineway Pharmaceutical Group Limited (the "Company") hereby announces that the Company has been informed that its principal share registrar and transfer office in the Cayman Islands has changed its name from "Codan Trust Company (Cayman) Limited" to "Conyers Trust Company (Cayman) Limited" with effect from 30 March 2017.
The address of the Company's principal share registrar and transfer office in the Cayman Islands remains unchanged.
By order of the Board
China Shineway Pharmaceutical Group Limited Li ZhenjiangChairman
Hong Kong, 10 April 2017
As at the date of this announcement, the executive Directors are Mr. Li Zhenjiang, Ms. Xin Yunxia, Mr. Li Huimin, Ms. Lee Ching Ton Brandelyn and Mr. Chen Zhong. The independent non-executive Directors are Ms. Cheng Li and Mr. Sun Liutai.
China Shineway Pharmaceutical Group Ltd. published this content on 10 April 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 10 April 2017 17:20:08 UTC.
Original documenthttp://shineway.todayir.com/attachment/2017041019170200002776259_en.pdf
Public permalinkhttp://www.publicnow.com/view/CD231329E0D374F39FF6769C40B310661B8FCE4F
